Skip to main content
SpringerLink
Log in

Secukinumab

Lack of efficacy and off-label use

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Melgosa Ramos FJ, et al. Long-term secukinumab efficacy in patients with moderate to severe hidradenitis suppurativa: A retrospective single-centre case series (23 patients). Journal of the European Academy of Dermatology and Venereology 37: e517-e519, No. 4, Apr 2023. Available from: URL: 10.1111/jdv.18685

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Secukinumab. Reactions Weekly 2008, 317 (2024). https://doi.org/10.1007/s40278-024-59211-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-59211-7

Search

Navigation